TP53 and esophageal cancer: A meta-analysis of 1497 cases reported by Zhang et al. indicated that wild-type form of p53 status (low expression of p53 protein and/or wild-type TP53 gene) was associated with high response to chemotherapy-based treatment in esophageal cancer.